Cognitive and brain reserve and the diagnosis and treatment of preclinical Alzheimer disease
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
“Reserve” hypotheses in neurodegenerative disease are theoretical concepts that attempt to explain how some individuals are able to maintain normal cognition despite pathologic disease burden sufficient to cause cognitive decline or overt dementia in others.1 This idea was born out of the seminal work of Katzman et al.2 who described, at postmortem, a subset of older individuals with preserved cognition who harbored substantial levels of neocortical plaques. To explain this disconnect between pathologic burden and clinical state, 2 “reserve” terms have been proposed. Brain reserve refers to intrinsic differences in brain structure or neuronal capacity and is measured by assessment of brain volume and by postmortem assessment of synaptic density and neuronal number or size.1,3 Cognitive reserve, on the other hand, refers to differences in how individuals utilize adaptive cognitive strategies and engage neural networks to maintain normal cognition in the face of pathologic burden.1 Cognitive reserve is traditionally measured by surrogate markers, such as overall ability level, and lifestyle factors, such as education, occupation, and cognitive, social, and physical leisure activities.4 With the advent of in vivo antemortem biomarkers of Alzheimer disease (AD) that allow us to quantify brain structure, function, and molecular composition, we now know that approximately 30% of elderly individuals with no clinical impairment have evidence for preclinical AD (pAD), indicated by abnormal Aβ levels by imaging or CSF analysis.1,5 As the field moves toward preclinical diagnosis and eventual treatment of individuals with pAD, it is critical that we understand the mediating factors of the relationships among cognition, function, and pathologic burden.6 One potential mediating factor is the influence of cognitive and brain reserve.
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
- © 2013 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.